MTSS1 and hepatocellular carcinoma: We found that patients with high MTSS1 expression manifested residual liver tumors early, higher number of metastatic lung nodules and lower 1-year survival rates, which suggests that HCC patients with high MTSS1 expression have a poor prognosis and a higher mortality following palliative hepatectomy.